Generic placeholder image

Anti-Infective Agents

Editor-in-Chief

ISSN (Print): 2211-3525
ISSN (Online): 2211-3533

Editorial

Mutations Unveiled: Navigating the Ever-Changing Landscape of SARSCoV-2 in the COVID-19 Saga

In Press, (this is not the final "Version of Record"). Available online 02 July, 2024
Author(s): Komal, Niraj Patil and Amandeep Singh*
Published on: 02 July, 2024

Article ID: e020724231473

DOI: 10.2174/0122113525303969240624071851

Price: $95

[1]
Pal, M.; Berhanu, G.; Desalegn, C.; Kandi, V. Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2): An update. Cureus, 2020, 12(3), e7423.
[http://dx.doi.org/10.7759/cureus.7423] [PMID: 32337143]
[2]
Lai, C.C.; Shih, T.P.; Ko, W.C.; Tang, H.J.; Hsueh, P.R. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges. Int. J. Antimicrob. Agents, 2020, 55(3), 105924.
[http://dx.doi.org/10.1016/j.ijantimicag.2020.105924] [PMID: 32081636]
[3]
Harvey, W.T.; Carabelli, A.M.; Jackson, B.; Gupta, R.K.; Thomson, E.C.; Harrison, E.M.; Ludden, C.; Reeve, R.; Rambaut, A.; Peacock, S.J.; Robertson, D.L. SARS-CoV-2 variants, spike mutations and immune escape. Nat. Rev. Microbiol., 2021, 19(7), 409-424.
[http://dx.doi.org/10.1038/s41579-021-00573-0] [PMID: 34075212]
[4]
Barzon, L.; Lavezzo, E.; Militello, V.; Toppo, S.; Palù, G. Applications of next-generation sequencing technologies to diagnostic virology. Int. J. Mol. Sci., 2011, 12(11), 7861-7884.
[http://dx.doi.org/10.3390/ijms12117861] [PMID: 22174638]
[5]
Tao, K.; Tzou, P.L.; Nouhin, J.; Gupta, R.K.; de Oliveira, T.; Kosakovsky Pond, S.L.; Fera, D.; Shafer, R.W. The biological and clinical significance of emerging SARS-CoV-2 variants. Nat. Rev. Genet., 2021, 22(12), 757-773.
[http://dx.doi.org/10.1038/s41576-021-00408-x] [PMID: 34535792]
[6]
Kendzerska, T.; Zhu, D.T.; Gershon, A.S.; Edwards, J.D.; Peixoto, C.; Robillard, R.; Kendall, C.E. The effects of the health system response to the COVID-19 pandemic on chronic disease management: A narrative review. Risk Manag. Healthc. Policy, 2021, 14, 575-584.
[http://dx.doi.org/10.2147/RMHP.S293471] [PMID: 33623448]
[7]
Young, A.; Neumann, B.; Mendez, R.F.; Reyahi, A.; Joannides, A.; Modis, Y. Homologous protein domains in SARS-CoV-2 and measles, mumps and rubella viruses: preliminary evidence that MMR vaccine might provide protection against COVID-19. MedRxiv, 2020, 2020.04.
[http://dx.doi.org/10.1101/2020.04.10.20053207]
[8]
Janik, E.; Niemcewicz, M.; Podogrocki, M.; Majsterek, I.; Bijak, M. The emerging concern and interest SARS-CoV-2 variants. Pathogens, 2021, 10(6), 633.
[http://dx.doi.org/10.3390/pathogens10060633] [PMID: 34064143]
[9]
Walensky, R.P.; Walke, H.T.; Fauci, A.S. SARS-CoV-2 variants of concern in the United States—challenges and opportunities. JAMA, 2021, 325(11), 1037-1038.
[http://dx.doi.org/10.1001/jama.2021.2294] [PMID: 33595644]
[10]
Kaur, G.; Singh, A.; Narang, R.K.; Singh, G. COVID-19 pandemic: Age and temperature related effects. Coronaviruses, 2021, 2(5), 11-19.
[http://dx.doi.org/10.2174/2666796701999200905095159]
[11]
Hoteit, R.; Yassine, H.M. Biological properties of SARS-CoV-2 variants: Epidemiological impact and clinical consequences. Vaccines, 2022, 10(6), 919.
[http://dx.doi.org/10.3390/vaccines10060919] [PMID: 35746526]

Rights & Permissions Print Cite
© 2025 Bentham Science Publishers | Privacy Policy